| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 27.914 | 33.394 | 39.020 | 51.075 | 50.737 | 51.274 | 57.630 | 82.224 | 87.811 |
| Total Income - EUR | - | 27.914 | 33.394 | 39.020 | 51.075 | 52.805 | 51.275 | 57.651 | 82.224 | 87.812 |
| Total Expenses - EUR | - | 14.339 | 20.390 | 27.287 | 29.073 | 25.715 | 22.119 | 18.644 | 19.748 | 26.330 |
| Gross Profit/Loss - EUR | - | 13.575 | 13.004 | 11.733 | 22.002 | 27.090 | 29.156 | 39.007 | 62.477 | 61.483 |
| Net Profit/Loss - EUR | - | 13.296 | 12.103 | 11.343 | 21.491 | 26.784 | 28.810 | 38.460 | 61.655 | 58.848 |
| Employees | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
Check the financial reports for the company - Dr. Găman Aurelia Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 600 | 21.960 | 17.726 | 12.829 | 7.453 | 2.592 | 1.464 | 1.171 | 878 |
| Current Assets | - | 13.678 | 16.438 | 24.640 | 19.757 | 26.609 | 29.590 | 38.984 | 64.443 | 61.092 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 2.447 | 3.123 | 3.467 | 4.624 | 4.803 | 4.941 | 27.070 | 42.948 | 40.927 |
| Cash | - | 11.231 | 13.315 | 21.173 | 15.133 | 21.806 | 24.649 | 11.914 | 21.496 | 20.166 |
| Shareholders Funds | - | 13.340 | 20.439 | 26.882 | 21.541 | 26.834 | 29.514 | 39.085 | 61.703 | 58.897 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.013 | 18.007 | 15.531 | 12.263 | 7.229 | 2.669 | 1.362 | 3.912 | 3.269 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dr. Găman Aurelia Srl